Nomura Holdings Inc Eli Lilly & CO Put Options Transaction History

Nomura Holdings Inc

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $17.5 Million - $23.4 Million	50,000 New	50,000 $23.4 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $68.7 Million - $80.8 Million	616,866 Added 1281.56%	665,000 $85.8 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $5.17 Million - $6.1 Million	-69,600 Reduced 59.12%	48,134 $3.72 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $3.57 Million - $4.22 Million	48,134 Added 69.16%	117,734 $9.61 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $3.84 Million - $4.12 Million	46,900 Added 206.61%	69,600 $5.88 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $1.75 Million - $1.94 Million	22,700	22,700 $1.94 Million

3,994

752M

7.31M

9.23M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.